VEGFA and hepatocellular carcinoma: It has been confirmed in mouse implanted with human HCC that inhibition of STAT3 activation by antisense oligonucleic acid not only reduces the expression of VEGF and MMP-2 but also reduces the microvascular density (MVD) of CD34 positive in tumor tissues, inhibiting tumor metastasis to the liver [19].